Table 3.
sqrt right RS ratio |
sqrt left RS ratio |
|||
---|---|---|---|---|
r | p | r | p | |
Anthropometric parameters | ||||
Agea | 0.30 | < 0.001 | 0.32 | < 0.001 |
BMI, kg/m2 | 0.37 | < 0.001 | 0.36 | < 0.001 |
WC, cm | 0.40 | < 0.001 | 0.36 | < 0.001 |
SBP, mm Hg | 0.12 | 0.213 | 0.13 | 0.104 |
DBP, mm Hg | 0.17 | 0.088 | 0.15 | 0.114 |
Adipose tissue measurements | ||||
sqrt RP,cm3 | 0.60 | < 0.001 | 0.52 | < 0.001 |
sqrt IP,cm3 | 0.50 | < 0.001 | 0.42 | < 0.001 |
sqrt SC, cm3 | 0.40 | < 0.001 | 0.35 | < 0.001 |
Kidney biochemical parameters | ||||
eGFREPI cyst&crea, ml/min/1.73 m2 | − 0.10 | 0.451 | − 0.17 | 0.330 |
Cystatin C, mg/l | 0.12 | 0.221 | 0.13 | 0.193 |
Creatinine, μmol/l | 0.02 | 0.856 | 0.04 | 0.703 |
Sqrt sKIM-1, pg/ml | 0.49 | 0.040 | 0.56 | 0.023 |
Sqrt FGF21, pg/ml | 0.57 | 0.001 | 0.64 | < 0.001 |
Glucose and lipid profile | ||||
Glucose, mmol/l | 0.03 | 0.897 | 0.06 | 0.717 |
Sqrt TG, mmol/l | 0.25 | 0.009 | 0.21 | 0.033 |
Sqrt HDLC, mmol/l | − 0.04 | 0.688 | − 0.05 | 0.626 |
Sqrt LDLC, mmol/l | − 0.22 | 0.024 | − 0.20 | 0.038 |
Inflammatory cytokine levels | ||||
Sqrt IL-6, pg/ml | − 0.25 | 0.107 | − 0.05 | 0.734 |
Sqrt TNFα, pg/ml | − 0.10 | 0.541 | − 0.12 | 0.450 |
sqrt – square root-transformation; RS – renal sinus; SC – subcutaneous adipose tissue; IP – intraperitoneal adipose tissue; RP – retroperitoneal adipose tissue; RSRatio - ratio of RS adipose tissue volume to corresponding total kidney size; BMI – body mass index; WC – waist circumference; SBP - systolic blood pressure; DBP – diastolic blood pressure; eGFREPI cyst&crea – estimated glomerular filtration rate; sKIM-1 – serum kidney injury molecule-1; FGF-21 – fibroblast growth factor – 21; TG – triglycerides; HDLC – high density lipoprotein cholesterol; LDLC - low density lipoprotein cholesterol; IL-6 – interleukin 6; TNFα - tumor necrosis factor alpha. The level of significance was set as p < 0.05.
Data show the gender adjusted partial Pearson correlation.